Ignite Creation Date:
2024-05-05 @ 6:30 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00491400
Status:
TERMINATED
Last Update Posted:
2012-10-24
First Post:
2007-06-22
Brief Title:
Effect of a Fibrate and a Statin on Endothelial Dysfunction
Sponsor:
Boston University
Organization:
Boston University
Study Overview
Official Title:
Effect of a Fibrate Fenofibrate and a Statin Atorvastatin and on Endothelial Dysfunction in Diabetes Mellitus and the Metabolic Syndrome
Status:
TERMINATED
Status Verified Date:
2012-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Insufficient enrollment
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study will compare the effect of atorvastatin to the effect of fenofibrate on endothelial function in patients with diabetes mellitus or the metabolic syndrome
Detailed Description:
The study will compare the effect of atorvastatin to the effect of fenofibrate on endothelial function in patients with diabetes mellitus or the metabolic syndrome The study is a double blind placebo controlled crossover study with the order of treatment randomized Patients will receive each treatment for 8 weeks with a 1 week rest period between treatment periods Endothelial function will be tested using non-invasive techniques before and after each treatments A total of 40 subjects with diabetes or the metabolic syndrome will be enrolled at Boston Medical Center
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None